Insider buying on Aug 7, 2026

On Aug 7, 2026, 44 insiders at 29 companies filed 58 purchases reported on Form 4, worth $71.1M in all, with a median purchase of $31.5K. The largest was Forbion Growth Opportunities Fund III Cooperatief U.A., 10% owner of Braveheart Bio, Inc. (BRVE), who reported buying 1,920,000 shares worth $34.6M. Officers accounted for 20 purchases, directors who are not officers for 28, and 10% owners with no board or officer role for 10. Chief executives and chief financial officers filed 7 purchases: Murdoch Travis, CEO and President, Director of Braveheart Bio, Inc. (BRVE); Sprink Eric M, CEO, Director of Coastal Financial Corp (CCB); Dempsey Robert John, CHIEF EXECUTIVE OFFICER, Director of OKYO Pharma Ltd (OKYO) among others. 11 companies showed cluster buying, two or more insiders buying within 7 days, among them BRVE (10 insiders), ATTO (6 insiders), OKYO (6 insiders), GBFH (5 insiders). For 16 insiders of 44, this was the first purchase of that company's stock on our record. That is more than the 44 purchases filed on Aug 6, 2026. A Form 4 is due within two business days of the trade, so most of these purchases were made earlier in the week. Code P also covers shares bought privately from the company, so one large figure can be a negotiated placement rather than buying on the exchange.